| Year |
Citation |
Score |
| 2016 |
Gerrin SJ, Sowalsky AG, Balk SP, Ye H. Mutation profiling indicates high grade prostatic intraepithelial neoplasia as distant precursors of adjacent invasive prostatic adenocarcinoma. The Prostate. PMID 27272561 DOI: 10.1002/pros.23212 |
0.56 |
|
| 2016 |
Gao S, Ye H, Gerrin S, Wang H, Sharma A, Chen S, Patnaik A, Sowalsky AG, Voznesensky O, Han W, Yu Z, Mostaghel E, Nelson PS, Taplin ME, Balk SP, et al. ErbB2 Signaling Increases Androgen Receptor Expression in Abiraterone-Resistant Prostate Cancer. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 26936914 DOI: 10.1158/1078-0432.CCR-15-2309 |
0.56 |
|
| 2015 |
Kumar S, Lu B, Dixit U, Hossain S, Liu Y, Li J, Hornbeck P, Zheng W, Sowalsky AG, Kotula L, Birge RB. Reciprocal regulation of Abl kinase by Crk Y251 and Abi1 controls invasive phenotypes in glioblastoma. Oncotarget. PMID 26473374 DOI: 10.18632/oncotarget.6096 |
0.56 |
|
| 2015 |
Sowalsky AG, Sager R, Schaefer RJ, Bratslavsky G, Pandolfi PP, Balk SP, Kotula L. Loss of Wave1 gene defines a subtype of lethal prostate cancer. Oncotarget. 6: 12383-91. PMID 25906751 |
0.56 |
|
| 2015 |
Chen EJ, Sowalsky AG, Gao S, Cai C, Voznesensky O, Schaefer R, Loda M, True LD, Ye H, Troncoso P, Lis RL, Kantoff PW, Montgomery RB, Nelson PS, Bubley GJ, et al. Abiraterone treatment in castration-resistant prostate cancer selects for progesterone responsive mutant androgen receptors. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 21: 1273-80. PMID 25320358 DOI: 10.1158/1078-0432.CCR-14-1220 |
0.56 |
|
| 2015 |
Sowalsky AG, Xia Z, Wang L, Zhao H, Chen S, Bubley GJ, Balk SP, Li W. Whole transcriptome sequencing reveals extensive unspliced mRNA in metastatic castration-resistant prostate cancer. Molecular Cancer Research : McR. 13: 98-106. PMID 25189356 DOI: 10.1158/1541-7786.MCR-14-0273 |
0.56 |
|
| 2014 |
Yu Z, Chen S, Sowalsky AG, Voznesensky OS, Mostaghel EA, Nelson PS, Cai C, Balk SP. Rapid induction of androgen receptor splice variants by androgen deprivation in prostate cancer. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 20: 1590-600. PMID 24449822 DOI: 10.1158/1078-0432.CCR-13-1863 |
0.56 |
|
| 2013 |
Cai C, Wang H, He HH, Chen S, He L, Ma F, Mucci L, Wang Q, Fiore C, Sowalsky AG, Loda M, Liu XS, Brown M, Balk SP, Yuan X. ERG induces androgen receptor-mediated regulation of SOX9 in prostate cancer. The Journal of Clinical Investigation. 123: 1109-22. PMID 23426182 DOI: 10.1172/JCI66666 |
0.56 |
|
| 2013 |
Sowalsky AG, Ye H, Bubley GJ, Balk SP. Clonal progression of prostate cancers from Gleason grade 3 to grade 4. Cancer Research. 73: 1050-5. PMID 23204237 DOI: 10.1158/0008-5472.CAN-12-2799 |
0.56 |
|
| 2011 |
Alt-Holland A, Sowalsky AG, Szwec-Levin Y, Shamis Y, Hatch H, Feig LA, Garlick JA. Suppression of E-cadherin function drives the early stages of Ras-induced squamous cell carcinoma through upregulation of FAK and Src. The Journal of Investigative Dermatology. 131: 2306-15. PMID 21716326 DOI: 10.1038/jid.2011.188 |
0.56 |
|
| 2011 |
Sowalsky AG, Alt-Holland A, Shamis Y, Garlick JA, Feig LA. RalA function in dermal fibroblasts is required for the progression of squamous cell carcinoma of the skin. Cancer Research. 71: 758-67. PMID 21159665 DOI: 10.1158/0008-5472.CAN-10-2756 |
0.56 |
|
| 2010 |
Sowalsky AG, Alt-Holland A, Shamis Y, Garlick JA, Feig LA. RalA suppresses early stages of Ras-induced squamous cell carcinoma progression. Oncogene. 29: 45-55. PMID 19802010 DOI: 10.1038/onc.2009.307 |
0.56 |
|
| Show low-probability matches. |